Clinical Trials Directory

Trials / Completed

CompletedNCT01444495

Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Jagiellonian University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to establish the influence of time-interval between preoperative hyperfractionated radiotherapy (5x5 Gy) and surgery on long term overall survival (5 years), local and distant recurrence rate, downstaging rate, sphincter saving procedures, radical resection rate (R0) in patients with locally advanced rectal cancer operated on according to TME technique. In particular 3D endosonography and 3rd generation ultrasonic contrast agents are evaluated to assess response to radiotherapy.

Detailed description

The treatment group comprises patients with locally advanced rectal cancer who were operated on in the 1st Department of General Surgery, Jagiellonian University, Cracow. The data on survival has been systematically collected using national census registry. Patients are qualified to preoperative radiotherapy 5x5 Gy and then randomly assigned to subgroups with different time interval between radiotherapy and surgery: one subgroup consists of patients operated on 7-10 days after the end of irradiation, the second subgroup consists of patients operated on after 4-5 weeks. Both should be homogenous in sex, age, cancer stage and localization, distal and circumferential resection margins, number of resected lymph nodes. 3D endorectal ultrasound and endorectal ultrasound with SonoVue are performed to assess the tumor before and after preoperative radiotherapy.

Conditions

Interventions

TypeNameDescription
RADIATIONPreoperative radiotherapyPreoperative radiotherapy 5x5 Gy (total dose of 25 Gy)
PROCEDURESurgeryTotal mesorectal excision of rectal cancer

Timeline

Start date
1999-01-01
Primary completion
2008-06-01
Completion
2010-12-01
First posted
2011-09-30
Last updated
2023-02-15

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT01444495. Inclusion in this directory is not an endorsement.